<DOC>
	<DOC>NCT02479139</DOC>
	<brief_summary>The purpose of this study is to establish the therapeutic range of ANT-1207 in the treatment of primary axillary hyperhidrosis.</brief_summary>
	<brief_title>Clinical Trial To Evaluate ANT-1207 In Subjects With Primary Axillary Hyperhidrosis</brief_title>
	<detailed_description />
	<mesh_term>Hyperhidrosis</mesh_term>
	<criteria>ages 18 70 years of age diagnosis of primary axillary hyperhidrosis HDSS score of â‰¥3 threshold sweat production/axilla in 5 minutes as measured gravimetrically willingness to shave underarms prior to each study visit botulinum toxin treatment in the prior 6 months signs of infection in the axilla skin affliction in the axilla requiring medical treatment oral anticholinergic treatment use of antiperspirants, deodorants, powders, or lotions use of axillary depilatories or axillary epilation history of surgery or other interventions for axillary hyperhidrosis female subjects who are pregnant or are nursing a child</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>